Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03608618 |
|
Recruitment Status :
Terminated
(Sponsor shift in focus)
First Posted : August 1, 2018
Last Update Posted : September 5, 2021
|
Sponsor:
MaxCyte, Inc.
Collaborator:
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
MaxCyte, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | February 11, 2021 |
| Actual Study Completion Date : | August 24, 2021 |